THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

APP Pharmaceuticals names new CEO, chief financial officer

Email|Print|Single Page| Text size – +
May 1, 2008

SCHAUMBURG, Ill.—Injection maker APP Pharmaceuticals Inc. said Thursday it named Thomas H. Silberg as president and chief executive, succeeding Patrick Soon-Shoing, who will remain chairman.

The company also said Richard J. Tajak will become chief financial officer, succeeding Lisa Gopala.

Both Soon-Shoing and Gopala served in their roles under a shared services arrangement following the separation of APP and Abraxis BioScience in November.

Silberg, 61, has served as APP's president since November, and before that was president of Abraxis Pharmaceutical Products (the division name of APP prior to the separation).

Tajak, 55, joined APP in March as senior vice president of finance. He served most recently as senior vice president of finance for the North American operations of Astellas Pharmaceuticals Inc.

© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.